[go: up one dir, main page]

ATE128728T1 - Interferon-gamma bindende proteine. - Google Patents

Interferon-gamma bindende proteine.

Info

Publication number
ATE128728T1
ATE128728T1 AT89121094T AT89121094T ATE128728T1 AT E128728 T1 ATE128728 T1 AT E128728T1 AT 89121094 T AT89121094 T AT 89121094T AT 89121094 T AT89121094 T AT 89121094T AT E128728 T1 ATE128728 T1 AT E128728T1
Authority
AT
Austria
Prior art keywords
protein
interferon
binding proteins
gamma binding
molecule
Prior art date
Application number
AT89121094T
Other languages
English (en)
Inventor
Daniela Novick
Yves Mory
Dina G Fischer
Michel Revel
Menachem Rubinstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE128728T1 publication Critical patent/ATE128728T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT89121094T 1988-11-14 1989-11-14 Interferon-gamma bindende proteine. ATE128728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8837888A IL88378A (en) 1988-11-14 1988-11-14 Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
ATE128728T1 true ATE128728T1 (de) 1995-10-15

Family

ID=11059418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89121094T ATE128728T1 (de) 1988-11-14 1989-11-14 Interferon-gamma bindende proteine.

Country Status (9)

Country Link
US (1) US5763210A (de)
EP (1) EP0369413B1 (de)
JP (1) JP3104187B2 (de)
AT (1) ATE128728T1 (de)
AU (1) AU620466B2 (de)
CA (1) CA2002833C (de)
DE (1) DE68924464T2 (de)
ES (1) ES2080060T3 (de)
IL (1) IL88378A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
CA2070416A1 (en) * 1989-10-23 1991-04-24 Richard Ingram Polypeptide inhibitors of gamma interferon
DE69104356T2 (de) * 1990-04-24 1995-03-02 Schering Corp Lösliche verkürzte interferon-gamma rezeptoren.
DE69322289T2 (de) 1992-12-29 1999-05-20 Genentech, Inc., South San Francisco, Calif. Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
US7704944B2 (en) * 1997-08-14 2010-04-27 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
AU2003285874A1 (en) 2002-10-16 2004-05-04 Amgen Inc. HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS
US20190185559A1 (en) * 2016-09-02 2019-06-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating neoplasias

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
AU625866B2 (en) * 1989-04-19 1992-07-16 F. Hoffmann-La Roche Ag Soluble interferon-gamma receptors and methods for their production

Also Published As

Publication number Publication date
AU4469889A (en) 1990-05-31
IL88378A (en) 2000-11-21
EP0369413A2 (de) 1990-05-23
EP0369413B1 (de) 1995-10-04
JP3104187B2 (ja) 2000-10-30
IL88378A0 (en) 1989-06-30
AU620466B2 (en) 1992-02-20
CA2002833C (en) 2001-10-30
CA2002833A1 (en) 1990-05-14
US5763210A (en) 1998-06-09
DE68924464D1 (de) 1995-11-09
DE68924464T2 (de) 1996-03-28
ES2080060T3 (es) 1996-02-01
EP0369413A3 (en) 1990-09-26
JPH02291269A (ja) 1990-12-03

Similar Documents

Publication Publication Date Title
DK0737207T3 (da) Inhibitorer for humant plasmin afledt af Kunitz-domæner
ATE184052T1 (de) Gdf-1 und uog1 proteine
DK75694A (da) Tumornecrosefaktor og derivater og mutantformer deraf, fremgangsmåde til fremstilling deraf, DNA som koder derfor, replicerbar udtrykkelsesvektor indeholdende DNA'en og celle transformeret dermed samt præparater omfattende tumornecrosefaktoren
ATE226634T1 (de) Fibronektin bindendes protein
ATE128728T1 (de) Interferon-gamma bindende proteine.
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
ES2107520T3 (es) Endoproteasa dibasica recombinante situada en el reticulo endoplasmico y usos de la misma.
FI940036A (fi) Nukleotidisekvenssejä ja sykloheksimidiresistenssejä proteiineja
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
AU1141695A (en) Interferon-alpha/beta binding protein, its preparation and use
DE69333467D1 (de) Bordetella bronchiseptica impfstoff
EP0723016A3 (de) Leukocyten-aktivierender Faktor
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
FI893942A0 (fi) Faktorreglerande genexpression.
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time